Judge Andrews recently granted defendant’s motions to exclude two of plaintiff’s experts in Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc., C.A. No. 10-805-RGA (D. Del. July 17, 2012). Judge Andrews excluded plaintiff’s patent law expert because the report and testimony would not assist the trier of fact. Id. at 1. Judge Andrews also excluded, as cumulative and redundant, plaintiff’s chemistry expert, “with the understanding that Defendant will not object based on the expert discovery rules to Plaintiff’s other ‘esteemed nucleoside chemist’ covering the same material[.]” Id.